Zhejiang HISUN Biomaterials Co. Ltd. A Capital Reinvestment Ratio

Latest as of December 2024: 7.55x

Zhejiang HISUN Biomaterials Co. Ltd. A capital reinvestment ratio. Zhejiang HISUN Biomaterials Co. Ltd. A (688203) has a Capital Reinvestment Ratio of 7.55x as of December 2024, meaning it reinvests 8% of its operating cash flow (CN¥38.84 Million) in capital expenditures (CN¥293.18 Million). Check 688203 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

7.55x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥38.84 Million
CNY

Capital Expenditures

CN¥293.18 Million
CNY

Data as of

Dec 2024
Most recent filing

Capital Reinvestment Ratio of Zhejiang HISUN Biomaterials Co. Ltd. A (2020–2024)

Capital reinvestment ratio of Zhejiang HISUN Biomaterials Co. Ltd. A from 2020 to 2024. This chart tracks Zhejiang HISUN Biomaterials Co. Ltd. A's Capital Reinvestment Ratio across 5 annual periods. Also explore Zhejiang HISUN Biomaterials Co. Ltd. A net asset momentum to track the company's year-over-year net asset growth rate.

Zhejiang HISUN Biomaterials Co. Ltd. A Capital Reinvestment Ratio by Year (2020–2024)

Zhejiang HISUN Biomaterials Co. Ltd. A capital reinvestment ratio by year from 2020 to 2024. For the full cash flow conversion analysis, see 688203 cash flow metrics.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 7.55x CN¥38.84 Million CN¥293.18 Million ▲ +474.8%
2023 1.31x CN¥163.03 Million CN¥214.11 Million ▼ -20.6%
2022 1.65x CN¥136.15 Million CN¥225.27 Million ▼ -61.9%
2021 4.35x CN¥71.18 Million CN¥309.44 Million ▼ -37.1%
2020 6.91x CN¥28.66 Million CN¥198.08 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow